天美传媒

ISSN: 2167-065X

Clinical Pharmacology & Biopharmaceutics
天美传媒 Access

Our Group organises 3000+ Global Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ 天美传媒 Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

天美传媒 Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)
  • Short Communication   
  • Clin Pharmacol Biopharm 2023, Vol 12(7): 356
  • DOI: 10.4172/2167-065X.1000356

Advancements in Personalized Medicine: Transforming Pharmaceutical Industry

Julie Saleh*
Department of Psychiatry and Behavioral Sciences, University of Washington, 325 Ninth Avenue, Box 359911, Seattle, USA
*Corresponding Author : Julie Saleh, Department of Psychiatry and Behavioral Sciences, University of Washington, 325 Ninth Avenue, Box 359911, Seattle, USA, Email: Julie.saleh22@gmail.com

Received Date: Jul 03, 2023 / Published Date: Jul 28, 2023

Citation: Saleh J (2023) Advancements in Personalized Medicine: Transforming Pharmaceutical Industry. Clin Pharmacol Biopharm, 12: 356. Doi: 10.4172/2167-065X.1000356

Copyright: © 2023 Saleh J. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

Select your language of interest to view the total content in your interested language

Post Your Comment Citation
Share This Article
Article Tools
Article Usage
  • Total views: 1634
  • [From(publication date): 0-2023 - Jan 02, 2026]
  • Breakdown by view type
  • HTML page views: 1309
  • PDF downloads: 325
International Conferences 2026-27
 
Meet Inspiring Speakers and Experts at our 3000+ Global

Conferences by Country

Medical & Clinical Conferences

Conferences By Subject

Top Connection closed successfully.